How to Thrive in a New Health Care Ecosystem:
Recommendations for Hemophilia Providers to Address Payer Challenges

• Release Date: January 31, 2017
• Expiration Date: July 31, 2018
• Estimated Time to Complete Activity: 1.5 hours
• Compatible with all modern browsers and mobile devices

DISTINGUISHED FACULTY

Jeffrey Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx/MagellanRx Click here for biography John Fox, MD, MHA Vice President, Associate Chief Medical Officer Medical Affairs Priority Health Click here for biography James Jorgenson, MS, RPh, FASHP Chief Executive Officer Board Chair Visante, Inc. Click here for biography John Knispel MD, CPE, FACOG Regional Medical Director (Ret) Commercial Markets Florida Humana Inc. Click here for biography James Kenney, Jr., RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care Click here for biography Celynda G. Tadlock, PharmD, MBA Vice President, Pharmacy Business Development Aetna Click here for biography Vanita K. Pindolia, PharmD, BCPS Vice President, Ambulatory Clinical Pharmacy Programs_PCM Henry Ford Health System/Health Alliance Plan of Michigan Click here for biography

TARGET AUDIENCE

• This activity is designed specifically for HTC clinicians including physicians, registered nurses, and social workers.

Statement of Need/Program Overview
Due to the advent of new and more costly treatment modalities, the management of pediatric and adult hemophilia patients has become more complex for physicians, physician assistants, registered nurses, nurse practitioners, social workers, case managers, payers, specialty pharmacies, home health providers, and family/caregivers. In the absence of a coordinated educational effort, the full benefits of care coordination and the comprehensive care model have not yet been achieved.

EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be able to demonstrate improved ability to:

• Describe strategies used by managed care organizations (MCOs) and specialty pharmacy providers to facilitate care and administer benefits for members with hemophilia
• Employ techniques for hemophilia providers to improve communications with health plans, insurers, and specialty pharmacy providers
• Recommend payer processes for streamlining pre-certification and prior authorization
• Apply methods to enable optimal cost management of factor replacement therapy to be realized by multiple hemophilia stakeholders including Medicaid Plans, specialty pharmacy providers, and other MCOs

ACCREDITATION

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, the National Hemophilia Foundation, and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This educational activity for 1.5 contact hours is provided by the Postgraduate Institute for Medicine.

Social Worker Continuing Education
This program is Approved by the National Association of Social Workers (Approval # 886733890-0) for 1.5 Social Work continuing education contact hours.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period January 31, 2017 through July 31, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, your certificate will be made available immediately to download and print.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.